Search clinical trials for: NNC9204-1177
Total 256 results
-
POINT BiopharmaActive, not recruitingSoft Tissue Sarcoma | Colorectal Cancer | Esophageal Cancer | Cholangiocarcinoma | Head and Neck Squamous Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Melanoma (Skin)United States, Canada
-
Bivision Pharmaceuticals, Inc.Recruiting
-
Nanjing First Hospital, Nanjing Medical UniversityUnknownMetastatic Castration-resistant Prostate CancerChina
-
Idience Co., Ltd.Active, not recruitingSolid Tumors | Homologous Recombination Deficiency | Homologous Recombination Repair Gene MutationKorea, Republic of
-
Leo WangBTS InternationalCompletedHypertension | Efficacy of Wrist BPM MeasurementChina
-
Allena PharmaceuticalsCompletedEnteric Hyperoxaluria | Primary Hyperoxaluria | HyperoxalemiaUnited States, United Kingdom, Germany
-
Jonsson Comprehensive Cancer CenterPOINT BiopharmaActive, not recruitingProstate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma | Recurrent Prostate AdenocarcinomaUnited States
-
BioCryst PharmaceuticalsCompletedLeukemia, Lymphocytic, ChronicUnited States
-
Novartis PharmaceuticalsCompletedNeuroendocrine TumorUnited States
-
National Cancer Center, ChinaNot yet recruiting
-
Idience Co., Ltd.RecruitingGastric CancerKorea, Republic of, United States, China
-
Peter MacCallum Cancer Centre, AustraliaRecruitingProstate Cancer | Metastatic Castration-resistant Prostate Cancer | mCRPCAustralia
-
Lantheus Medical ImagingPOINT BiopharmaAvailableCastration-Resistant Prostatic CancerUnited States
-
Aclaris Therapeutics, Inc.CompletedAtopic DermatitisUnited States
-
Santen Inc.CompletedPrimary Open-angle Glaucoma and Ocular HypertensionUnited States
-
Ralph NULL SalloumChildren's Hospital Medical Center, CincinnatiRecruitingHigh Grade Glioma | Medulloblastoma | Meningioma | Anaplastic Ependymoma | Recurrent Malignant Glioma | Recurrent Medulloblastoma | Refractory Malignant Glioma | Refractory Medulloblastoma | Recurrent Diffuse Intrinsic Pontine Glioma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary... and other conditionsUnited States
-
Santen Pharmaceutical Co., Ltd.CompletedHealthy Male AdultsJapan
-
Cellbion Co., Ltd.Recruiting
-
Lawson Health Research InstituteActive, not recruiting
-
Advanced Accelerator ApplicationsActive, not recruitingNeuroendocrine TumorsUnited Kingdom, Portugal, Spain, France, United States
-
Allena PharmaceuticalsTerminatedEnteric HyperoxaluriaUnited States, Spain, United Kingdom, Portugal, Romania, Canada, Austria, Belgium, Brazil, Croatia, France, Germany, Italy, Mexico, Russian Federation, Switzerland
-
Providence Health & ServicesExelixis; Advanced Accelerator Applications SAActive, not recruitingNeuroendocrine TumorsUnited States
-
University of IowaNovartisNot yet recruitingNeuroendocrine Tumors | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1United States
-
University College, LondonNot yet recruitingMedullary Thyroid Carcinoma | Bronchial and Thymic Neuroendocrine Tumour | Paraganglioma/ Phaeochromocytoma | Those Requiring Repeat Peptide Receptor Radionuclide Therapy
-
Marnix LamCompletedNeuroendocrine Tumors | Liver MetastasesNetherlands
-
University of MiamiMallinckrodtCompleted
-
Wakayama Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
POINT Biopharma, a wholly owned subsidiary of Eli...Active, not recruitingMetastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, Sweden, France, United Kingdom
-
Celldex TherapeuticsCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma | Marginal Zone B Cell Lymphoma) | Any T-cell Malignancy | Solid Tumors (Metastatic Melanoma, Renal (Clear) Cell Carcinoma | Hormone-refractory Prostate Adenocarcinoma, Ovarian... and other conditionsUnited States
-
Radboud University Medical CenterCompleted
-
AHS Cancer Control AlbertaCross Cancer InstituteActive, not recruiting
-
Max Zeller Soehne AGUnknownDrug Interaction StudyGermany
-
Tine Gregersen, MDRecruitingNeuroendocrine NeoplasmDenmark
-
HiberCell, Inc.Celldex TherapeuticsTerminatedMetastatic Pancreatic AdenocarcinomaUnited States
-
AHS Cancer Control AlbertaRecruitingCarcinoma, NeuroendocrineCanada
-
David BushnellNational Cancer Institute (NCI); National Institutes of Health (NIH); Progenics...WithdrawnNeuroendocrine Tumors | Gastro-enteropancreatic Neuroendocrine TumorUnited States
-
Radboud University Medical CenterCompletedMetastatic Clear Cell Renal Cell CarcinomaNetherlands
-
Santen Inc.Completed
-
National Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation | Metastatic Prostate Neuroendocrine CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Digestive System Neuroendocrine Neoplasm | Metastatic Neuroendocrine TumorUnited States
-
Vadim S KoshkinEli Lilly and Company; Prostate Cancer FoundationActive, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Castration-resistant Prostate Cancer | Metastatic Prostate Adenocarcinoma | Metastatic Castration-resistant Prostate CarcinomaUnited States
-
Remedy Pharmaceuticals, Inc.TerminatedA Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain Contusion (ASTRAL)Brain ContusionIsrael, Spain, United States, Germany, Italy, Japan, France
-
National Cancer Institute (NCI)RecruitingMetastatic Midgut Neuroendocrine Tumor | Unresectable Midgut Neuroendocrine Tumor | Metastatic Midgut Neuroendocrine Tumor G1 | Metastatic Midgut Neuroendocrine Tumor G2United States, Canada
-
Santen Pharmaceutical Co., Ltd.CompletedPrimary Open Angle Glaucoma | Ocular HypertensionJapan
-
Imperial College LondonAdvanced Accelerator Applications International SARecruiting
-
National Cancer Institute (NCI)Active, not recruitingPlasmablastic Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell... and other conditionsUnited States
-
Remedy Pharmaceuticals, Inc.U.S. Army Medical Research and Development Command; INTRuST, Post-Traumatic...Completed
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)Active, not recruitingRefractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8United States
-
National Cancer Institute (NCI)Recruiting
-
Stanford UniversityNovartis PharmaceuticalsRecruitingGastroenteropancreatic Neuroendocrine TumorUnited States